Treatment outcomes for one-stage concurrent surgical resection and reconstruction of synchronous esophageal and head and neck squamous cell carcinoma
- 22 July 2019
- journal article
- research article
- Published by Springer Science and Business Media LLC in European Archives Of Oto-Rhino-Laryngology
- Vol. 276 (10), 2929-2940
- https://doi.org/10.1007/s00405-019-05564-9
Abstract
Purpose It is not uncommon to see the synchronous presentation of esophageal squamous carcinoma (ESCC) and head and neck cancer (HNC), and most patients were treated with staged interventions. This study retrospectively reported the outcomes of patients with synchronous ESCC and HNC treated with one-stage concurrent surgical resection and reconstruction. Methods We identified 17 consecutive patients with synchronous ESCC and HNC undergoing primary concurrent surgical resections between 2011 and 2017 at our hospital. All patients had received esophageal screenings prior to treatment. Results The HNC patients in this study had the following subsite involvements: oral cavity (n = 5), oropharynx (n = 4), larynx (n = 1), hypopharynx (n = 9), and thyroid gland (n = 1). Eighty percent of the HNC subsites (16/20) were treated in advanced stages, while most ESCCs were treated at early stages. The mean follow-up time was 3.2 ± 1.6 years. Surgery-associated morbidity and mortality were 94.1% and 0%, respectively, and the most common complication was anastomotic leakage. The two-year overall survival, 2-year loco-regional recurrence-free survival, and 2-year distant metastasis-free survival were 86.7%, 85.6%, and 78.7%, respectively. No significant difference was found between overall survival and HNC subsite or anastomotic leakage. Four patients (23.5%) developed secondary primary malignancies (SPMs) within a mean follow-up period of 2.9 years (standard deviation 1.6 years). Conclusion Although one-stage concurrent surgical resection and reconstruction of synchronous ESCC and HNC were highly invasive and complicated, survival was promising. Isolated distant metastasis remained the most common failure pattern. Vigilant follow-up strategy is mandatory to detect secondary primary malignancies (SPMs), especially within the first 3 years following initial treatment.Keywords
This publication has 52 references indexed in Scilit:
- Surgical strategies for esophageal cancer associated with head and neck cancerSurgery Today, 2013
- Effect of Routine Esophageal Screening in Patients With Head and Neck CancerJAMA Otolaryngology–Head & Neck Surgery, 2013
- Surgical Resection for Esophageal Cancer Synchronously or Metachronously Associated with Head and Neck CancerAnnals of Surgical Oncology, 2013
- Second Primary Cancers After an Index Head and Neck Cancer: Subsite-Specific Trends in the Era of Human Papillomavirus–Associated Oropharyngeal CancerJournal of Clinical Oncology, 2011
- Salvage esophagectomy after definitive chemoradiotherapy for synchronous double cancers of the esophagus and head-and-neckDiseases of the Esophagus, 2010
- Alcohol and Tobacco Use Prediagnosis and Postdiagnosis, and Survival in a Cohort of Patients with Early Stage Cancers of the Oral Cavity, Pharynx, and LarynxCancer Epidemiology, Biomarkers & Prevention, 2009
- Refined Geographic Distribution of the Oriental ALDH2*504Lys (nee 487Lys) VariantAnnals of Human Genetics, 2009
- VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic nicheNature, 2005
- Patterns of failure, prognostic factors and survival in locoregionally advanced head and neck cancer treated with concomitant chemoradiotherapy: a 9-year, 337-patient, multi-institutional experienceAnnals Of Oncology, 2004
- Use of the “supercharge” technique in esophageal and pharyngeal reconstruction to augment microvascular blood flowSurgery, 2003